Natsuki Takano

Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer

Teppei Sugano, Masahiro Seike, Yoshinobu Saito et al. · Thoracic Cancer · 2020 · 51 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Exosome‐derived <scp>miR</scp>‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition in <scp><i>EGFR</i></scp> mutant non‐small cell lung cancer cells

Kakeru Hisakane, Masahiro Seike, Teppei Sugano et al. · Thoracic Cancer · 2021 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017

Natsuki Takano, Ryo Ariyasu, Junji Koyama et al. · Lung Cancer · 2019 · 43 citations

Medicine, Oncology, Surgery +11

Inhibitors of <scp>ABCB1</scp> and <scp>ABCG2</scp> overcame resistance to topoisomerase inhibitors in small cell lung cancer

Miwako Omori, Rintaro Noro, Masahiro Seike et al. · Thoracic Cancer · 2022 · 36 citations · Full text

Medicine, Oncology, Pharmacology +16

Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study

Aya Fukuizumi, Yuji Minegishi, Miwako Omori et al. · International Journal of Clinical Oncology · 2019 · 33 citations

Medicine, Oncology, Pharmacology +11